Our Pricing

Weight Loss Treatment UK Online Pharmacy

Published on: June 03, 2026

Looking for trusted weight loss treatment UK online pharmacy options? At Cured Pharmacy, we provide access to the latest prescription weight loss medications including Mounjaro, Wegovy, Saxenda, and Orlistat, all with transparent upfront pricing, free clinical consultations with UK prescribers, and discreet next-day delivery across the United Kingdom.

How Modern Weight Loss Treatments Work

The latest generation of weight loss medications work by targeting the body's natural appetite and blood sugar regulation systems. GLP-1 receptor agonists like semaglutide and liraglutide mimic incretin hormones that signal fullness to the brain, slow gastric emptying, and improve insulin sensitivity [1]. Tirzepatide takes this further as the first dual GIP/GLP-1 receptor agonist, activating two complementary pathways for enhanced metabolic effects.

In the landmark STEP trials, once-weekly semaglutide (Wegovy) demonstrated an average body weight reduction of 14.9% over 68 weeks in adults with obesity, compared to 2.4% with placebo [2]. The SURMOUNT-1 trial showed even greater results with tirzepatide (Mounjaro), with participants achieving up to 22.5% average weight reduction at the highest dose over 72 weeks [3]. These medications are licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with weight-related comorbidities.

Orlistat works through a different mechanism entirely, blocking approximately 30% of dietary fat absorption in the intestines [4]. While producing more modest weight loss of 5-10% on average, it remains an effective option for patients who prefer oral medication or cannot tolerate injectable treatments.

Mounjaro: The Most Effective Weight Loss Treatment Available

Mounjaro (tirzepatide) represents the most significant advancement in obesity medicine in recent years. As the first dual GIP/GLP-1 receptor agonist, it activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, producing superior weight loss outcomes compared to single-pathway medications [3].

Clinical trial data shows remarkable efficacy: in SURMOUNT-1, 91% of participants on the 15mg dose achieved at least 5% weight loss, whilst 57% achieved 20% or greater weight reduction [3]. The medication is administered once weekly via a pre-filled KwikPen injection device, with doses gradually increased over several months to minimise gastrointestinal side effects.

At Cured Pharmacy, Mounjaro is available from £135.00 following a free online consultation with our UK-registered prescribers. All patients undergo thorough clinical assessment to ensure suitability, and our pharmacist team provides comprehensive guidance on injection technique, dose escalation, and managing potential side effects.

Who Can Take Mounjaro?

Mounjaro is licensed for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea. It is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Your UK prescriber will assess your full medical history during the consultation to determine suitability.

Wegovy and Saxenda: Proven GLP-1 Weight Loss Options

Wegovy (semaglutide) and Saxenda (liraglutide) are both established GLP-1 receptor agonists with extensive clinical evidence supporting their use in weight management. Wegovy is administered once weekly and demonstrated average weight loss of 14.9% in the STEP 1 trial, making it significantly more effective than older weight loss medications [2].

Saxenda requires daily injections but offers a lower starting price point at £135.00, making it accessible for patients seeking a more budget-friendly injectable option. Clinical trials showed an average weight loss of 8% over 56 weeks with liraglutide 3.0mg daily [5]. Both medications work by reducing appetite, increasing feelings of fullness, and slowing gastric emptying.

The choice between these treatments depends on individual factors including injection frequency preference, budget considerations, and previous treatment response. Our UK prescribers will discuss your lifestyle, weight loss goals, and medical history to recommend the most appropriate option during your free consultation.

Wegovy vs Saxenda: Key Differences

The primary difference lies in dosing frequency: Wegovy requires just one injection weekly, whilst Saxenda is administered daily. Wegovy generally produces greater weight loss on average, but Saxenda's daily dosing allows for more gradual dose adjustments. Both are prescription-only medications requiring clinical assessment by a UK prescriber before dispensing.

Orlistat and Xenical: Oral Weight Loss Medication

For patients who prefer oral medication or cannot tolerate injectable treatments, Orlistat offers an effective alternative. Available in 60mg (Alli, Orlos) and 120mg (Xenical, generic Orlistat) strengths, it works by inhibiting pancreatic and gastric lipases, preventing approximately 30% of dietary fat from being absorbed [4].

Clinical studies demonstrate that Orlistat 120mg three times daily, combined with a reduced-calorie diet, produces an average weight loss of 5-10% over 12 months [4]. The medication is taken with each main meal containing fat, up to three times daily. Patients must follow a reduced-fat diet to minimise gastrointestinal side effects such as oily stools and increased bowel movements.

At Cured Pharmacy, generic Orlistat 120mg starts from £135.00, Xenical from £135.00, and lower-dose Orlos 60mg from £135.00. All strengths require an online consultation with our UK prescribers, who will assess your suitability and provide dietary guidance to optimise results whilst minimising side effects.

Your Online Consultation Process at Cured Pharmacy

Our streamlined online consultation takes under 3 minutes to complete and is reviewed by UK-registered prescribers within hours. You'll answer questions about your weight history, current medications, medical conditions, and previous weight loss attempts. This information allows our clinical team to assess suitability and recommend the most appropriate treatment for your circumstances.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511) where our pharmacist team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), dispense your medication. We provide detailed patient information leaflets, injection technique guides for injectable treatments, and ongoing support throughout your weight loss journey.

All medications are dispatched in 100% discreet packaging with next-day delivery options available across the UK. We guarantee the lowest prices in the UK market and display transparent pricing before consultation, so you know the exact cost before proceeding. Repeat prescriptions are simple to arrange through your online account, with automatic reminders ensuring you never run out of medication.

What Happens After Your Consultation?

Once a UK prescriber approves your treatment, you'll receive email confirmation with tracking details. Your medication typically arrives within 24 hours in discreet packaging. For injectable treatments, we include comprehensive administration guides and sharps disposal information. Our pharmacy team remains available via phone (+44 116 4646009) for any questions about your treatment.

Safety, Side Effects, and Long-Term Management

All prescription weight loss medications carry potential side effects that must be carefully considered. GLP-1 receptor agonists commonly cause gastrointestinal symptoms including nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation [1][2]. These effects typically diminish over several weeks as your body adjusts to the medication.

More serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications. Injectable GLP-1 treatments carry a boxed warning regarding thyroid C-cell tumours observed in animal studies, though human relevance remains uncertain [1]. Your prescriber will review your personal and family medical history to identify any contraindications before prescribing.

Orlistat's side effects are primarily gastrointestinal and directly related to its mechanism of blocking fat absorption. Patients may experience oily spotting, flatulence with discharge, and urgent bowel movements, especially when consuming high-fat meals [4]. These effects can be minimised by following a reduced-fat diet containing no more than 30% of calories from fat.

Long-term weight management requires ongoing treatment in most cases. Clinical trials show that discontinuing GLP-1 medications typically results in weight regain [2]. Our UK prescribers recommend combining medication with sustainable lifestyle changes including balanced nutrition and regular physical activity to optimise long-term success. Regular follow-up consultations allow for dose adjustments and monitoring of treatment response.

Managing Side Effects Effectively

Starting with the lowest dose and increasing gradually helps minimise gastrointestinal side effects with injectable treatments. Eating smaller, more frequent meals and avoiding high-fat foods can reduce nausea. For Orlistat, strictly limiting dietary fat to 15-20g per meal prevents uncomfortable bowel-related side effects. Contact our pharmacy team immediately if you experience severe abdominal pain, persistent vomiting, or signs of pancreatitis.

Scientific References

1. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Sjöström, L., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
5. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.